Mesothelioma; Pleura
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma (NCT04300244) | Åslaug Helland | 2020-05-04 |
| Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer (NCT03907852) | TCR2 Therapeutics | 2019-04-15 |
Track Mesothelioma; Pleura automatically
Every clearance here is in the API, with alerts when new ones post.